SOLUTION NMR

NMR Experiment
Experiment Type Sample Contents Ionic Strength Solvent pH Pressure Temprature (K)
1 2D 1H-15N HSQC 0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O 0.45 90% H2O/10% D2O 5.0 1 298
2 2D 1H-13C HSQC 0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O 0.45 90% H2O/10% D2O 5.0 1 298
3 3D CBCA(CO)NH 0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O 0.45 90% H2O/10% D2O 5.0 1 298
4 3D C(CO)NH 0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O 0.45 90% H2O/10% D2O 5.0 1 298
5 3D HNCO 0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O 0.45 90% H2O/10% D2O 5.0 1 298
6 3D HNCACB 0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O 0.45 90% H2O/10% D2O 5.0 1 298
7 3D H(CCO)NH 0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O 0.45 90% H2O/10% D2O 5.0 1 298
8 3D HCCH-TOCSY 0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O 0.45 90% H2O/10% D2O 5.0 1 298
9 3D HNHA 0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O 0.45 90% H2O/10% D2O 5.0 1 298
10 3D 1H-15N NOESY 0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O 0.45 90% H2O/10% D2O 5.0 1 298
11 3D 1H-13C NOESY 0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O 0.45 90% H2O/10% D2O 5.0 1 298
12 3D aromatic 1H-13C NOESY 0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O 0.45 90% H2O/10% D2O 5.0 1 298
NMR Spectrometer Information
Spectrometer Manufacturer Model Field Strength
1 Varian INOVA 600
NMR Refinement
Method Details Software
simulated annealing, torsion angle dynamics ? 1
NMR Ensemble Information
Conformer Selection Criteria structures with the lowest energy
Conformers Calculated Total Number 20
Conformers Submitted Total Number 20
Representative Model 1 (closest to the average)
Computation: NMR Software
# Classification Version Software Name Author
1 data analysis 5.2.2 NMRView Johnson
2 structure solution 1.1 CNS Brunger, Adams, Clore, Gros, Nilges and Read
3 refinement 1.1 CNS Brunger, Adams, Clore, Gros, Nilges and Read
Feedback Form
Name
Email
Institute
Feedback